Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical anti-viral agents; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections
REGISTERED
on 24 May 2023
TARSELZYME
GENZYME CORPORATION
2025797 · 01 May 2020
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical anti-viral agents; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections
Pharmaceutical preparations for the prevention and treatment of cardio...